409 related articles for article (PubMed ID: 16474852)
1. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
[TBL] [Abstract][Full Text] [Related]
3. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1.
Kinjyo I; Inoue H; Hamano S; Fukuyama S; Yoshimura T; Koga K; Takaki H; Himeno K; Takaesu G; Kobayashi T; Yoshimura A
J Exp Med; 2006 Apr; 203(4):1021-31. PubMed ID: 16606674
[TBL] [Abstract][Full Text] [Related]
4. Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma.
Wu WY; Kim H; Zhang CL; Meng XL; Wu ZS
J Invest Surg; 2014 Aug; 27(4):197-204. PubMed ID: 24476004
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats.
Bagnyukova TV; Tryndyak VP; Muskhelishvili L; Ross SA; Beland FA; Pogribny IP
Cell Cycle; 2008 Oct; 7(20):3202-10. PubMed ID: 18843197
[TBL] [Abstract][Full Text] [Related]
6. HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3.
Yuan K; Lei Y; Chen HN; Chen Y; Zhang T; Li K; Xie N; Wang K; Feng X; Pu Q; Yang W; Wu M; Xiang R; Nice EC; Wei Y; Huang C
Cell Death Differ; 2016 Apr; 23(4):616-27. PubMed ID: 26794444
[TBL] [Abstract][Full Text] [Related]
7. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma.
Jiang LH; Hao YL; Zhu JW
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):282-291. PubMed ID: 30385249
[TBL] [Abstract][Full Text] [Related]
10. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
[TBL] [Abstract][Full Text] [Related]
11. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
13. Interference of suppressor of cytokine signaling 3 promotes epithelial-mesenchymal transition in MHCC97H cells.
Ji YY; Wang ZD; Li ZF; Li K
World J Gastroenterol; 2013 Feb; 19(6):866-73. PubMed ID: 23430705
[TBL] [Abstract][Full Text] [Related]
14. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta promotes Th17 cell development through inhibition of SOCS3.
Qin H; Wang L; Feng T; Elson CO; Niyongere SA; Lee SJ; Reynolds SL; Weaver CT; Roarty K; Serra R; Benveniste EN; Cong Y
J Immunol; 2009 Jul; 183(1):97-105. PubMed ID: 19535626
[TBL] [Abstract][Full Text] [Related]
16. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.
Riehle KJ; Campbell JS; McMahan RS; Johnson MM; Beyer RP; Bammler TK; Fausto N
J Exp Med; 2008 Jan; 205(1):91-103. PubMed ID: 18158318
[TBL] [Abstract][Full Text] [Related]
17. Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
Wang C; Dai J; Yang M; Deng G; Xu S; Jia Y; Boden G; Ma ZA; Yang G; Li L
FEBS J; 2014 May; 281(9):2136-47. PubMed ID: 24593051
[TBL] [Abstract][Full Text] [Related]
18. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
Int Immunopharmacol; 2017 Aug; 49():203-211. PubMed ID: 28601022
[TBL] [Abstract][Full Text] [Related]
20. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
